CTS Awarded Best Classroom Training Manual at 2006 PDA Biennial Training Conference
May 22, 2006
Clinical Trial Services (CTS) was awarded the PDA Trainer’s Choice Award for “Best Classroom Training Manual” at the 2006 PDA Biennial Training Conference in Philadelphia, May 8-12. This award is presented biannually to professional trainers by their peers for outstanding achievement in design, development and delivery of pharmaceutical cGMP and technical training programs.
The award-winning program, “GMP Training: Clinical Trial Blinding – Is That What I Think It IS?” provides background and hands-on experience in the area of “Blinding” (or masking) of clinical trial products. This program presents information in an interactive format using employee groups made up of every department at CTS. It is divided into two sessions and facilitated by the training and quality departments at CTS.
Led by CTS Training Manager Jacqueline Tusman, instructional designers and trainers include:
Lisa Anderson, Trainer
Troy Suessmuth, QC Manager
Al Benedict, QC Supervisor
Chris Groff, QC Supervisor
Barry Kerr, QC Supervisor
Tina Starson, QC Supervisor
Other 2006 Trainer’s Choice Award recipients include:
About the Conference
The PDA Biennial Training Conference and accompanying training courses and exhibition aims to help pharmaceutical and biopharmaceutical companies ensure they have well-trained workforces to implement new technologies effectively and efficiently. Themed, “Training… A Winning Strategy,” this year’s conference featured 35 concurrent sessions covering five learning tracks with the goal of helping delegates develop actionable strategies for business success.
Connecting People, Science and Regulationsm
The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.
CTS is a globally positioned company focused on provision of solutions for clinical trial supplies. CTS enables client companies to meet their trial start dates by leveraging of experienced staff and flexibility with robust quality systems. Services provided by CTS include blinding, packaging, labelling, global distribution, QP release, analytical testing, drug supply management and online randomisation via the WEBEZTM system.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and Almac Diagnostic Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.